Skip to main content
. 2022 Jan 18;24(4):526–536. doi: 10.1007/s11307-021-01700-2

Table 1.

Comparative study of imaging modalities to assess COVID-19 clinical manifestation

HRCT / U-HRCT DECT CTPA SPECT-CT EIT
Principle of technique Transmission tomography Transmission tomography Transmission tomography Emission (SPECT) and transmission (CT) tomography Transmission tomography
Energy source X-rays produced by single high voltage (125 kVp) tube X-rays produced by two low and high voltages (80 and 140 kVp) tubes X-rays produced by single high voltage (120 kVp) tube Photons (99mTc:140 keV, 81mKr: 190 keV, 123I: 159 keV) emitted by SPECT radiotracer and X-ray from CT tube (30–80 kVp) Low intensity alternating electrical current
Signal production mechanism Attenuation of X-rays in the lungs Attenuation of X-rays in the lungs and pulmonary blood vessels Attenuation of X-rays in the lungs and pulmonary blood vessels Emission of photons from SPECT radiotracer and attenuation of CT X-rays in the lungs Resistivity to the electrical current (bioimpedance) produced by air in the lungs during inspiration and expiration
Radiation exposure Exposure to X-rays Exposure to X-rays Exposure to X-rays Exposure to radioactivity and X-rays No radiation exposure
Effective radiation dose 1 mSv per chest scan 1.5–3 mSv per chest scan 7–10 mSv per chest scan 6–7 mSv per SPECT/CT chest scan Not applicable
Contrast agent Contrast agent not required. FRI algorithm assesses vasculature on the stack of CT images of ≤ 1-mm thickness Iodinated contrast agents are used to visualize perfusion and pulmonary embolism in the lungs Iodinated contrast agents are used to visualize perfusion and pulmonary embolism in the lungs Contrast agent not required 5–7.5% w/v hypertonic sodium chloride intravenous bolus injection serves as contrast agent to measure lung perfusion
Radiotracers No radioactivity involved No radioactivity involved No radioactivity involved 99mTc-MAA,99mTc-DTPA, Technegas®, and 81mKr No radioactivity involved
Findings GGO, consolidation, pleural effusion, fibrosis, and microcystic honeycombing on lung CT images. Using FRI algorithm, redistribution of blood from smaller caliber blood vessels to dilated ones in GGO was observed GGO and consolidation on transmission scan, hyperperfusion in GGO, and hypoperfusion in apparently normal zone on iodine map; pulmonary infarction and embolism on perfusion scan were observed GGO and plural abnormalities on transmission scan; perfusion defects in normal and abnormal lung zones and pulmonary embolism may be detected Decreased radioactivity uptake in the infract zone on perfusion ventilation scan and decreased radioactivity distribution in COPD lungs on ventilation scan Unequal regional bioimpedance during respiration display ventilation perfusion mismatch, distention, or % collapse of the lung in four quadrants
Frequency of scans One-time scan in asymptomatic to severe patients and follow-up scans in long haulers during rehabilitation process One time or intermittent scans in moderate to severe patients to assess lung perfusion and pulmonary embolism site One time or intermittent scans in moderate to severe patients to assess lung perfusion and pulmonary embolism site One time or intermittent scans in moderate to severe patients to assess lung ventilation, and perfusion Continuous bedside examination of lung ventilation and perfusion in moderate to severe condition and evaluation of drug therapy
Patient group preferred Adults and pediatric Adults and pediatric without renal complications when using contrast agents Adults and pediatric without renal complications when using contrast agents Adults and only perfusion SPECT scan in pregnancy Adults, infants, pregnant, pediatric

HRCT high-resolution computed tomography, U-HRCT ultra high-resolution computed tomography, DECT dual energy computed tomography, CTPA conventional computed tomography pulmonary angiography SPECT-CT single photon emission tomography- computed tomography, EIT electrical impedance tomography, GGO ground-glass opacities, FRI functional respiratory imaging, COPD chronic obstructive pulmonary disease, 99mTc-MAA Technetium 99mTc macro-aggregated albumin, 99mTc-DTPA Technetium 99mTc-diethylen-tetraamino-pentaacetate, Technegas® ultra-fine dispersion of 99mTc-carbon, 81mKr 81 m krypton gas